The p53-dependent negative regulation of D2 results in enhanced TH action in a p53 null context and explains a recent emerging notion that THs promote the progression of cancer toward malignancy and that tumors expressing high D2 levels are characterized by lower percent survival and higher recurrence10. The gene discussed is TP53; the disease is cancer.